Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 478

1.

Pragmatic evaluation of inhaled corticosteroid particle size formulations on asthma control.

Kuo CR, Jabbal S, Anderson W, Lipworth BJ.

Clin Exp Allergy. 2019 Jul 1. doi: 10.1111/cea.13453. [Epub ahead of print]

PMID:
31264282
2.

Single Triple vs Dual Inhaler Therapy.

Lipworth BJ, Kuo CRW.

Chest. 2019 May;155(5):1078-1079. doi: 10.1016/j.chest.2019.01.030. No abstract available.

PMID:
31060693
3.

Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD.

Lipworth BJ, Kuo CRW.

Eur Respir J. 2019 Feb 14;53(2). pii: 1802420. doi: 10.1183/13993003.02420-2018. Print 2019 Feb. No abstract available.

PMID:
30765485
4.

Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA.

Lipworth BJ, Collier DJ, Gon Y, Zhong N, Nishi K, Chen R, Arora S, Maes A, Siddiqui S, Reisner C, Martin UJ.

Int J Chron Obstruct Pulmon Dis. 2018 Sep 26;13:2969-2984. doi: 10.2147/COPD.S171835. eCollection 2018.

5.

Disconnection of pulmonary and systemic arterial stiffness in COPD.

Weir-McCall JR, Liu-Shiu-Cheong PS, Struthers AD, Lipworth BJ, Houston JG.

Int J Chron Obstruct Pulmon Dis. 2018 May 28;13:1755-1765. doi: 10.2147/COPD.S160077. eCollection 2018.

6.

What can we learn about COPD from impulse oscillometry?

Lipworth BJ, Jabbal S.

Respir Med. 2018 Jun;139:106-109. doi: 10.1016/j.rmed.2018.05.004. Epub 2018 May 16. Review.

PMID:
29857993
7.

Does the asthma visual analog scale relate to the Asthma Control Questionnaire?

Jabbal S, Lipworth BJ.

Ann Allergy Asthma Immunol. 2018 May;120(5):533-535. doi: 10.1016/j.anai.2017.12.026. Epub 2018 Mar 21. No abstract available.

PMID:
29573960
8.

Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling.

Weir-McCall JR, Liu-Shiu-Cheong PS, Struthers AD, Lipworth BJ, Houston JG.

Eur Radiol. 2018 Aug;28(8):3464-3472. doi: 10.1007/s00330-018-5346-x. Epub 2018 Feb 27.

9.

Effects of contrast administration on cardiac MRI volumetric, flow and pulse wave velocity quantification using manual and software-based analysis.

Fathi A, Weir-McCall JR, Struthers AD, Lipworth BJ, Houston G.

Br J Radiol. 2018 Apr;91(1084):20170717. doi: 10.1259/bjr.20170717. Epub 2018 Jan 19.

10.

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD.

Jabbal S, Lipworth BJ.

Lung. 2018 Feb;196(1):15-18. doi: 10.1007/s00408-017-0079-1. Epub 2017 Dec 20.

11.

Blood eosinophils: The forgotten man of inhaled steroid dose titration.

Jabbal S, Lipworth BJ.

Clin Exp Allergy. 2018 Jan;48(1):93-95. doi: 10.1111/cea.13057. Epub 2017 Dec 1. No abstract available.

PMID:
29117628
12.

Un-diagnosing persistent adult asthma.

Lipworth BJ, Jabbal S.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701433. doi: 10.1183/13993003.01433-2017. Print 2017 Nov. No abstract available.

13.

Tolerability of Bisoprolol on Domiciliary Spirometry in COPD.

Jabbal S, Lipworth BJ.

Lung. 2018 Feb;196(1):11-14. doi: 10.1007/s00408-017-0061-y. Epub 2017 Oct 14.

PMID:
29030687
14.

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

Jabbal S, Anderson W, Short P, Morrison A, Manoharan A, Lipworth BJ.

QJM. 2017 Jul 24. doi: 10.1093/qjmed/hcx155. [Epub ahead of print]

PMID:
29025008
15.

Drug-device interaction for systemic effects of fluticasone in patients with asthma.

Lipworth BJ, Jabbal S.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):194. doi: 10.1016/j.anai.2017.01.023. No abstract available.

PMID:
28801019
16.

Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.

Silkoff PE, Flavin S, Gordon R, Loza MJ, Sterk PJ, Lutter R, Diamant Z, Turner RB, Lipworth BJ, Proud D, Singh D, Eich A, Backer V, Gern JE, Herzmann C, Halperin SA, Mensinga TT, Del Vecchio AM, Branigan P, San Mateo L, Baribaud F, Barnathan ES, Johnston SL.

J Allergy Clin Immunol. 2018 Apr;141(4):1220-1230. doi: 10.1016/j.jaci.2017.06.027. Epub 2017 Jul 20.

17.

Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.

Jabbal S, Manoharan A, Lipworth BJ.

Clin Exp Allergy. 2017 Oct;47(10):1239-1245. doi: 10.1111/cea.12972. Epub 2017 Aug 1.

PMID:
28665534
18.

Reappraisal of the clinical effect of mepolizumab.

Lipworth BJ, Jabbal S.

Lancet Respir Med. 2017 Jun;5(6):e20. doi: 10.1016/S2213-2600(17)30183-2. Epub 2017 May 26. No abstract available.

PMID:
28664852
19.

The case for impulse oscillometry in the management of asthma in children and adults.

Galant SP, Komarow HD, Shin HW, Siddiqui S, Lipworth BJ.

Ann Allergy Asthma Immunol. 2017 Jun;118(6):664-671. doi: 10.1016/j.anai.2017.04.009. Review.

20.

FULFIL an Unmet Need in Chronic Obstructive Pulmonary Disease.

Lipworth BJ, Jabbal S.

Am J Respir Crit Care Med. 2017 Oct 15;196(8):1082. doi: 10.1164/rccm.201704-0728LE. No abstract available.

PMID:
28534640
21.

Erratum to: Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers.

Nair A, McKinlay L, Williamson P, Short P, Burns P, Lipworth BJ.

Eur J Clin Pharmacol. 2017 Jun;73(6):793. doi: 10.1007/s00228-017-2259-6. No abstract available.

PMID:
28447126
22.

Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study.

Morales DR, Lipworth BJ, Donnan PT, Jackson C, Guthrie B.

BMC Med. 2017 Jan 27;15(1):18. doi: 10.1186/s12916-017-0781-0.

23.

Inhaled corticosteroid dose response in asthma: Should we measure inflammation?

Anderson WJ, Short PM, Jabbal S, Lipworth BJ.

Ann Allergy Asthma Immunol. 2017 Feb;118(2):179-185. doi: 10.1016/j.anai.2016.11.018. Epub 2017 Jan 3.

PMID:
28065396
24.

The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.

Edwards SC, Fairbrother SE, Scowcroft A, Chiu G, Ternouth A, Lipworth BJ.

Int J Chron Obstruct Pulmon Dis. 2016 Nov 22;11:2851-2858. eCollection 2016.

25.

IMPLICATION OF ALTERNATIVE MINIMAL CLINICALLY IMPORTANT DIFFERENCE THRESHOLD ESTIMATION METHODS ON TECHNOLOGY ASSESSMENT.

Brixner D, Meltzer EO, Morland K, Carroll CA, Munzel U, Lipworth BJ.

Int J Technol Assess Health Care. 2016 Jan;32(6):371-375. doi: 10.1017/S0266462316000593. Epub 2016 Dec 6.

PMID:
27919315
26.

Assessment of proximal pulmonary arterial stiffness using magnetic resonance imaging: effects of technique, age and exercise.

Weir-McCall JR, Kamalasanan A, Cassidy DB, Struthers AD, Lipworth BJ, Houston JG.

BMJ Open Respir Res. 2016 Oct 7;3(1):e000149. eCollection 2016.

27.

Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials.

Morales DR, Dreischulte T, Lipworth BJ, Donnan PT, Jackson C, Guthrie B.

Br J Clin Pharmacol. 2016 Sep;82(3):814-22. doi: 10.1111/bcp.13006. Epub 2016 Jun 17. Review.

28.

Letter to the editor: Comparing pace and speed in the pulmonary circulation?

Weir-McCall JR, Struthers AD, Lipworth BJ, Houston JG.

Am J Physiol Heart Circ Physiol. 2016 Apr 1;310(7):H949. doi: 10.1152/ajpheart.00065.2016. No abstract available.

29.

Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.

Manoharan A, Morrison AE, Lipworth BJ.

Lung. 2016 Apr;194(2):259-66. doi: 10.1007/s00408-015-9839-y. Epub 2016 Jan 13.

30.

Effects of the inverse alpha-agonist doxazosin in allergic rhinitis.

Manoharan A, Morrison AE, Lipworth BJ.

Clin Exp Allergy. 2016 May;46(5):696-704. doi: 10.1111/cea.12700.

PMID:
26741127
31.

From mouse to man: predicting biased effects of beta-blockers in asthma.

Lipworth BJ, Anderson WJ, Short PM.

Br J Pharmacol. 2016 Jan;173(1):248-9. doi: 10.1111/bph.13335. No abstract available.

32.

Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?

Currie GP, Lipworth BJ.

QJM. 2016 Aug;109(8):505-12. doi: 10.1093/qjmed/hcv212. Epub 2015 Nov 11. Review.

33.

Effects of formoterol or salmeterol on impulse oscillometry in patients with persistent asthma.

Manoharan A, von Wilamowitz-Moellendorff A, Morrison A, Lipworth BJ.

J Allergy Clin Immunol. 2016 Mar;137(3):727-33.e1. doi: 10.1016/j.jaci.2015.06.012. Epub 2015 Jul 26.

34.

Usefulness of impulse oscillometry for the assessment of airway hyperresponsiveness in mild-to-moderate adult asthma.

Short PM, Anderson WJ, Manoharan A, Lipworth BJ.

Ann Allergy Asthma Immunol. 2015 Jul;115(1):17-20. doi: 10.1016/j.anai.2015.04.022.

PMID:
26123421
35.

The role of pulmonary arterial stiffness in COPD.

Weir-McCall JR, Struthers AD, Lipworth BJ, Houston JG.

Respir Med. 2015 Nov;109(11):1381-90. doi: 10.1016/j.rmed.2015.06.005. Epub 2015 Jun 12. Review.

36.

Biomarkers to predict inhaled corticosteroid response.

Lipworth BJ.

J Allergy Clin Immunol. 2015 Aug;136(2):515. doi: 10.1016/j.jaci.2015.04.037. Epub 2015 Jun 9. No abstract available.

PMID:
26070882
37.

NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.

Morales DR, Guthrie B, Lipworth BJ, Jackson C, Donnan PT, Santiago VH.

Allergy. 2015 Jul;70(7):828-35. doi: 10.1111/all.12629. Epub 2015 May 7.

PMID:
25855099
38.

Impact of Left Ventricular Hypertrophy on Survival in Chronic Obstructive Pulmonary Disease.

Short PM, Anderson WJ, Elder DH, Struthers AD, Lipworth BJ.

Lung. 2015 Aug;193(4):487-95. doi: 10.1007/s00408-015-9724-8. Epub 2015 Mar 29.

PMID:
25821177
39.

Assessment of spirometry and impulse oscillometry in relation to asthma control.

Manoharan A, Anderson WJ, Lipworth J, Lipworth BJ.

Lung. 2015 Feb;193(1):47-51. doi: 10.1007/s00408-014-9674-6. Epub 2014 Dec 17.

PMID:
25516285
40.

Small airway dysfunction is associated with poorer asthma control.

Manoharan A, Anderson WJ, Lipworth J, Ibrahim I, Lipworth BJ.

Eur Respir J. 2014 Nov;44(5):1353-5. doi: 10.1183/09031936.00082314. Epub 2014 Jul 17. No abstract available.

41.

Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study.

Manoharan A, Short PM, Anderson WJ, Lipworth BJ.

Lung. 2014 Oct;192(5):649-52. doi: 10.1007/s00408-014-9611-8. Epub 2014 Jun 22.

PMID:
24952426
42.

The inverse agonist propranolol confers no corticosteroid-sparing activity in mild-to-moderate persistent asthma.

Anderson WJ, Short PM, Williamson PA, Manoharan A, Lipworth BJ.

Clin Sci (Lond). 2014 Dec;127(11):635-43. doi: 10.1042/CS20140249.

PMID:
24938324
43.

The potential role of direct and indirect bronchial challenge testing to identify overtreatment of community managed asthma.

Manoharan A, Lipworth BJ, Craig E, Jackson C.

Clin Exp Allergy. 2014 Oct;44(10):1240-5. doi: 10.1111/cea.12352.

PMID:
24912796
44.

Adrenal suppression with mometasone furoate/formoterol.

Lipworth BJ.

Chest. 2014 May;145(5):1175-1176. doi: 10.1378/chest.14-0143. No abstract available.

PMID:
24798853
45.

Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Goudie AR, Lipworth BJ, Hopkinson PJ, Wei L, Struthers AD.

Lancet Respir Med. 2014 Apr;2(4):293-300. doi: 10.1016/S2213-2600(14)70013-X. Epub 2014 Mar 5.

46.

Lack of clinically relevant differences between combination therapy and monotherapy in COPD.

Lipworth BJ.

Eur Respir J. 2014 Apr;43(4):1204. doi: 10.1183/09031936.00143513. No abstract available.

47.

Influence of β2-adrenoceptor 16 genotype on propranolol-induced bronchoconstriction in patients with persistent asthma.

Anderson WJ, Short PM, Manoharan A, Lipworth JL, Lipworth BJ.

Ann Allergy Asthma Immunol. 2014 May;112(5):475-6. doi: 10.1016/j.anai.2014.02.016. Epub 2014 Mar 18. No abstract available.

PMID:
24650443
48.

Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.

Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH.

J Allergy Clin Immunol. 2014 Jul;134(1):40-5. doi: 10.1016/j.jaci.2013.10.057. Epub 2013 Dec 31.

PMID:
24388008
49.

Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids.

Short PM, Anderson WJ, Williamson PA, Lipworth BJ.

Heart. 2014 Feb;100(3):219-23. doi: 10.1136/heartjnl-2013-304769. Epub 2013 Nov 7.

PMID:
24203262
50.

Adverse respiratory effect of acute β-blocker exposure in asthma: a systematic review and meta-analysis of randomized controlled trials.

Morales DR, Jackson C, Lipworth BJ, Donnan PT, Guthrie B.

Chest. 2014 Apr;145(4):779-786. doi: 10.1378/chest.13-1235. Review.

PMID:
24202435

Supplemental Content

Loading ...
Support Center